{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T11:18:58Z","timestamp":1794568738868,"version":"4.9.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T00:00:00Z","timestamp":1755648000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T00:00:00Z","timestamp":1755648000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81760587"],"award-info":[{"award-number":["81760587"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81760731"],"award-info":[{"award-number":["81760731"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Chin Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Sanren Decoction (SRD), a traditional Chinese medicine formula historically used to relieve damp-heat and gastrointestinal disorders, demonstrates targeted efficacy in ulcerative colitis (UC)\u2014a disease marked by chronic inflammation and mucosal damage\u2014by acting on multiple pathological pathways. This study employed an integrative methodology comprising network pharmacology, molecular docking, and in vivo experimentation to elucidate the underlying pharmacological mechanisms of SRD in the management of UC. The findings identified 87 genes targeted by SRD that are associated with UC, highlighting PTGS2 (Prostaglandin-Endoperoxide Synthase 2) as a crucial target involved in inflammatory processes. Molecular docking analysis confirmed significant interactions between the active compounds of SRD and PTGS2, suggesting a potential anti-inflammatory pathway. In vivo experiments utilizing a DSS-induced colitis mouse model demonstrated that SRD effectively ameliorates clinical symptoms and histopathological damage, enhances intestinal barrier integrity, and modulates macrophage polarization from a pro-inflammatory M1 state to an anti-inflammatory M2 phenotype. Furthermore, SRD was found to alter gut microbiota composition by increasing the abundance of beneficial bacteria and influencing metabolic pathways. These findings establish a strong scientific foundation for the potential of SRD as a comprehensive therapeutic approach for UC, offering promising prospects for its integration into clinical practice.<\/jats:p>","DOI":"10.1186\/s13020-025-01183-1","type":"journal-article","created":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T07:17:34Z","timestamp":1755674254000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Sanren decoction ameliorates ulcerative colitis by modulating gut microbiota and macrophage polarization to enhance intestinal barrier function"],"prefix":"10.1186","volume":"20","author":[{"given":"Shujuan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"BangHua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqun","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LinLin","family":"Ruan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingxing","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanglin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongtao","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojian","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4684-0318","authenticated-orcid":false,"given":"Dan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,20]]},"reference":[{"issue":"18","key":"1183_CR1","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1056\/NEJMra1102942","volume":"365","author":"S Danese","year":"2011","unstructured":"Danese S, Fiocchi C. Ulcerative colitis. N Engl J Med. 2011;365(18):1713\u201325.","journal-title":"N Engl J Med"},{"issue":"2","key":"1183_CR2","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1142\/S0192415X2550017X","volume":"53","author":"H Xu","year":"2025","unstructured":"Xu H, Zhu J, Lin X, Chen C, Tao J. A comprehensive review of traditional Chinese medicine in the management of ulcerative colitis. Am J Chin Med. 2025;53(2):435\u201373.","journal-title":"Am J Chin Med"},{"issue":"5","key":"1183_CR3","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1053\/j.gastro.2015.08.001","volume":"149","author":"DP McGovern","year":"2015","unstructured":"McGovern DP, Kugathasan S, Cho JH. Genetics of inflammatory bowel diseases. Gastroenterology. 2015;149(5):1163-1176. e2.","journal-title":"Gastroenterology"},{"issue":"5","key":"1183_CR4","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s00535-015-1064-1","volume":"50","author":"D Sheehan","year":"2015","unstructured":"Sheehan D, Moran C, Shanahan F. The microbiota in inflammatory bowel disease. J Gastroenterol. 2015;50(5):495\u2013507.","journal-title":"J Gastroenterol"},{"issue":"7351","key":"1183_CR5","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/nature10209","volume":"474","author":"B Khor","year":"2011","unstructured":"Khor B, Gardet A, Xavier RJ. Genetics and pathogenesis of inflammatory bowel disease. Nature. 2011;474(7351):307\u201317.","journal-title":"Nature"},{"issue":"1","key":"1183_CR6","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/S0016-5085(98)70381-6","volume":"115","author":"C Fiocchi","year":"1998","unstructured":"Fiocchi C. Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology. 1998;115(1):182\u2013205.","journal-title":"Gastroenterology"},{"issue":"3","key":"1183_CR7","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S1734-1140(11)70575-8","volume":"63","author":"AB Pithadia","year":"2011","unstructured":"Pithadia AB, Jain S. Treatment of inflammatory bowel disease (IBD). Pharmacol Rep. 2011;63(3):629\u201342.","journal-title":"Pharmacol Rep"},{"issue":"11\u201312","key":"1183_CR8","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1111\/j.1365-2036.2008.03856.x","volume":"28","author":"A Buckland","year":"2008","unstructured":"Buckland A, Bodger K. The cost-utility of high dose oral mesalazine for moderately active ulcerative colitis. Aliment Pharmacol Ther. 2008;28(11\u201312):1287\u201396.","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"1183_CR9","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.bpg.2016.02.005","volume":"30","author":"LA Derikx","year":"2016","unstructured":"Derikx LA, Dieleman LA, Hoentjen F. Probiotics and prebiotics in ulcerative colitis. Best Pract Res Clin Gastroenterol. 2016;30(1):55\u201371.","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"4","key":"1183_CR10","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1053\/j.gastro.2012.06.031","volume":"143","author":"A Vrieze","year":"2012","unstructured":"Vrieze A, Van Nood E, Holleman F, Saloj\u00e4rvi J, Kootte RS, Bartelsman JF, et al. Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology. 2012;143(4):913-6.e7.","journal-title":"Gastroenterology"},{"issue":"3","key":"1183_CR11","first-page":"463","volume":"34","author":"XM Chen","year":"2025","unstructured":"Chen XM, Zhou GQ, Ding YQ, Wang Y. Effects of modified Sanren decoction on intestinal mucosal barrier function, inflammatory cytokines, and oxidative stress levels in patients with acute-phase ulcerative colitis (damp-heat syndrome). Chin J Emerg Tradit Chin Med. 2025;34(3):463\u20137.","journal-title":"Chin J Emerg Tradit Chin Med"},{"issue":"3","key":"1183_CR12","first-page":"253","volume":"44","author":"ZP Wu","year":"2024","unstructured":"Wu ZP, Zhang YQ, Zeng GY, Chen WY, Zhang RZ, Wang MG, et al. Clinical thinking of Sanren Decoction treating ulcerative diseases based on the \u201cTriple Jiao Differentiation\u201d and \u201ctreating different diseases with the same prescription\u201d theories. Jilin J Tradit Chin Med. 2024;44(3):253\u20136.","journal-title":"Jilin J Tradit Chin Med"},{"issue":"3","key":"1183_CR13","first-page":"381","volume":"31","author":"XQ Chai","year":"2022","unstructured":"Chai XQ, Feng WZ, Lei B, Niu K, Shi P. Clinical study of modified Sanren Decoction in the treatment of acute-phase ulcerative colitis (damp-heat syndrome). Chin J Emerg Tradit Chin Med. 2022;31(3):381\u20133, 398.","journal-title":"Chin J Emerg Tradit Chin Med"},{"issue":"9","key":"1183_CR14","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/s41575-019-0172-4","volume":"16","author":"YR Na","year":"2019","unstructured":"Na YR, Stakenborg M, Seok SH, Matteoli G. Macrophages in intestinal inflammation and resolution: a potential therapeutic target in IBD. Nat Rev Gastroenterol Hepatol. 2019;16(9):531\u201343.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"9","key":"1183_CR15","doi-asserted-by":"publisher","first-page":"6425","DOI":"10.1002\/jcp.26429","volume":"233","author":"A Shapouri-Moghaddam","year":"2018","unstructured":"Shapouri-Moghaddam A, Mohammadian S, Vazini H, Taghadosi M, Esmaeili SA, Mardani F, et al. Macrophage plasticity, polarization, and function in health and disease. J Cell Physiol. 2018;233(9):6425\u201340.","journal-title":"J Cell Physiol"},{"issue":"1","key":"1183_CR16","doi-asserted-by":"publisher","first-page":"2","DOI":"10.2174\/1874467215666220324114624","volume":"16","author":"E Abdollahi","year":"2023","unstructured":"Abdollahi E, Johnston TP, Ghaneifar Z, Vahedi P, Goleij P, Azhdari S, et al. Immunomodulatory therapeutic effects of curcumin on M1\/M2 macrophage polarization in inflammatory diseases. Curr Mol Pharmacol. 2023;16(1):2\u201314.","journal-title":"Curr Mol Pharmacol"},{"key":"1183_CR17","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1146\/annurev-physiol-021909-135846","volume":"72","author":"JM Olefsky","year":"2010","unstructured":"Olefsky JM, Glass CK. Macrophages, inflammation, and insulin resistance. Annu Rev Physiol. 2010;72:219\u201346.","journal-title":"Annu Rev Physiol"},{"key":"1183_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2023.116306","volume":"309","author":"L Zhao","year":"2023","unstructured":"Zhao L, Zhang H, Li N, Chen J, Xu H, Wang Y, et al. Network pharmacology, a promising approach to reveal the pharmacology mechanism of Chinese medicine formula. J Ethnopharmacol. 2023;309: 116306.","journal-title":"J Ethnopharmacol"},{"issue":"18","key":"1183_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20184331","volume":"20","author":"L Pinzi","year":"2019","unstructured":"Pinzi L, Rastelli G. Molecular docking: shifting paradigms in drug discovery. Int J Mol Sci. 2019;20(18): 4331.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"1183_CR20","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/0016-5085(90)90290-H","volume":"98","author":"I Okayasu","year":"1990","unstructured":"Okayasu I, Hatakeyama S, Yamada M, Ohkusa T, Inagaki Y, Nakaya R. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology. 1990;98(3):694\u2013702.","journal-title":"Gastroenterology"},{"issue":"4","key":"1183_CR21","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/s41575-019-0258-z","volume":"17","author":"A Lavelle","year":"2020","unstructured":"Lavelle A, Sokol H. Gut microbiota-derived metabolites as key actors in inflammatory bowel disease. Nat Rev Gastroenterol Hepatol. 2020;17(4):223\u201337.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"10","key":"1183_CR22","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/nrgastro.2017.88","volume":"14","author":"J Ni","year":"2017","unstructured":"Ni J, Wu GD, Albenberg L, Tomov VT. Gut microbiota and IBD: causation or correlation? Nat Rev Gastroenterol Hepatol. 2017;14(10):573\u201384.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"11","key":"1183_CR23","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/nri2653","volume":"9","author":"JR Turner","year":"2009","unstructured":"Turner JR. Intestinal mucosal barrier function in health and disease. Nat Rev Immunol. 2009;9(11):799\u2013809.","journal-title":"Nat Rev Immunol"},{"issue":"14","key":"1183_CR24","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1182\/blood.2022017514","volume":"141","author":"X Zeng","year":"2023","unstructured":"Zeng X, Li X, Li X, Wei C, Shi C, Hu K, et al. Fecal microbiota transplantation from young mice rejuvenates aged hematopoietic stem cells by suppressing inflammation. Blood. 2023;141(14):1691\u2013707.","journal-title":"Blood"},{"issue":"3","key":"1183_CR25","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/nprot.2007.41","volume":"2","author":"S Wirtz","year":"2007","unstructured":"Wirtz S, Neufert C, Weigmann B, Neurath MF. Chemically induced mouse models of intestinal inflammation. Nat Protoc. 2007;2(3):541\u20136.","journal-title":"Nat Protoc"},{"key":"1183_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1197922","volume":"14","author":"H Zhao","year":"2023","unstructured":"Zhao H, Ding T, Chen Y, Yang W, Rao J, Liu D, et al. Arecoline aggravates acute ulcerative colitis in mice by affecting intestinal microbiota and serum metabolites. Front Immunol. 2023;14: 1197922.","journal-title":"Front Immunol"},{"issue":"4","key":"1183_CR27","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1007\/s00018-012-1070-x","volume":"70","author":"T Suzuki","year":"2013","unstructured":"Suzuki T. Regulation of intestinal epithelial permeability by tight junctions. Cell Mol Life Sci. 2013;70(4):631\u201359.","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"1183_CR28","doi-asserted-by":"publisher","first-page":"11","DOI":"10.5217\/ir.2015.13.1.11","volume":"13","author":"SH Lee","year":"2015","unstructured":"Lee SH. Intestinal permeability regulation by tight junction: implication on inflammatory bowel diseases. Intest Res. 2015;13(1):11\u20138.","journal-title":"Intest Res"},{"issue":"7","key":"1183_CR29","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/S1357-2725(98)00028-4","volume":"30","author":"A Allen","year":"1998","unstructured":"Allen A, Hutton DA, Pearson JP. The MUC2 gene product: a human intestinal mucin. Int J Biochem Cell Biol. 1998;30(7):797\u2013801.","journal-title":"Int J Biochem Cell Biol"},{"key":"1183_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2025.105721","volume":"116","author":"LA Schwerdtfeger","year":"2025","unstructured":"Schwerdtfeger LA, Montini F, Chitnis T, Cox LM, Weiner HL. Faecal mucoprotein MUC2 is decreased in multiple sclerosis and is associated with mucin degrading bacteria. EBioMedicine. 2025;116: 105721.","journal-title":"EBioMedicine"},{"issue":"39","key":"1183_CR31","doi-asserted-by":"publisher","first-page":"15064","DOI":"10.1073\/pnas.0803124105","volume":"105","author":"ME Johansson","year":"2008","unstructured":"Johansson ME, Phillipson M, Petersson J, Velcich A, Holm L, Hansson GC. The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria. Proc Natl Acad Sci U S A. 2008;105(39):15064\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"1183_CR32","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1053\/j.gastro.2006.04.020","volume":"131","author":"M Van der Sluis","year":"2006","unstructured":"Van der Sluis M, De Koning BA, De Bruijn AC, Velcich A, Meijerink JP, Van Goudoever JB, et al. Muc2-deficient mice spontaneously develop colitis, indicating that MUC2 is critical for colonic protection. Gastroenterology. 2006;131(1):117\u201329.","journal-title":"Gastroenterology"},{"issue":"3","key":"1183_CR33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0050054","volume":"5","author":"CK Heazlewood","year":"2008","unstructured":"Heazlewood CK, Cook MC, Eri R, Price GR, Tauro SB, Taupin D, et al. Aberrant mucin assembly in mice causes endoplasmic reticulum stress and spontaneous inflammation resembling ulcerative colitis. PLoS Med. 2008;5(3): e54.","journal-title":"PLoS Med"},{"issue":"6","key":"1183_CR34","first-page":"1297","volume":"21","author":"D Lissner","year":"2015","unstructured":"Lissner D, Schumann M, Batra A, Kredel LI, K\u00fchl AA, Erben U, May C, Schulzke JD, Siegmund B. Monocyte and M1 macrophage-induced barrier defect contributes to chronic intestinal inflammation in IBD. Inflamm Bowel Dis. 2015;21(6):1297\u2013305.","journal-title":"Inflamm Bowel Dis"},{"key":"1183_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2020.173090","volume":"877","author":"C Yunna","year":"2020","unstructured":"Yunna C, Mengru H, Lei W, Weidong C. Macrophage M1\/M2 polarization. Eur J Pharmacol. 2020;877: 173090.","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"1183_CR36","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s10456-013-9381-6","volume":"17","author":"N Jetten","year":"2014","unstructured":"Jetten N, Verbruggen S, Gijbels MJ, Post MJ, De Winther MP, Donners MM. Anti-inflammatory M2, but not pro-inflammatory M1 macrophages promote angiogenesis in vivo. Angiogenesis. 2014;17(1):109\u201318.","journal-title":"Angiogenesis"},{"issue":"1","key":"1183_CR37","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.immuni.2014.06.008","volume":"41","author":"PJ Murray","year":"2014","unstructured":"Murray PJ, Allen JE, Biswas SK, Fisher EA, Gilroy DW, Goerdt S, et al. Macrophage activation and polarization: nomenclature and experimental guidelines. Immunity. 2014;41(1):14\u201320.","journal-title":"Immunity"},{"issue":"21","key":"1183_CR38","doi-asserted-by":"publisher","first-page":"4111","DOI":"10.1007\/s00018-015-1995-y","volume":"72","author":"A Sica","year":"2015","unstructured":"Sica A, Erreni M, Allavena P, Porta C. Macrophage polarization in pathology. Cell Mol Life Sci. 2015;72(21):4111\u201326.","journal-title":"Cell Mol Life Sci"},{"issue":"3","key":"1183_CR39","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.00616-22","volume":"10","author":"A Pisani","year":"2022","unstructured":"Pisani A, Rausch P, Bang C, Ellul S, Tabone T, Marantidis Cordina C, et al. Dysbiosis in the gut microbiota in patients with inflammatory bowel disease during remission. Microbiol Spectr. 2022;10(3): e0061622.","journal-title":"Microbiol Spectr"},{"issue":"5","key":"1183_CR40","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1007\/s005350050147","volume":"33","author":"C Sakamoto","year":"1998","unstructured":"Sakamoto C. Roles of COX-1 and COX-2 in gastrointestinal pathophysiology. J Gastroenterol. 1998;33(5):618\u201324.","journal-title":"J Gastroenterol"},{"key":"1183_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2025.156827","volume":"143","author":"Y Jia","year":"2025","unstructured":"Jia Y, Liu X, Gao X, Yin S, Wu K, Meng X, et al. Plantamajoside alleviates DSS-induced ulcerative colitis by modulating gut microbiota, upregulating CBS, and inhibiting NF-\u03baB. Phytomedicine. 2025;143: 156827.","journal-title":"Phytomedicine"},{"issue":"8","key":"1183_CR42","doi-asserted-by":"publisher","first-page":"4109","DOI":"10.1039\/D4FO00835A","volume":"15","author":"WW Zhang","year":"2024","unstructured":"Zhang WW, Thakur K, Zhang JG, Wei ZJ. Riboflavin ameliorates intestinal inflammation via immune modulation and alterations of gut microbiota homeostasis in DSS-colitis C57BL\/6 mice. Food Funct. 2024;15(8):4109\u201321.","journal-title":"Food Funct"},{"key":"1183_CR43","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/978-3-319-41342-6_15","volume":"929","author":"T Yamada","year":"2016","unstructured":"Yamada T, Sugimoto K. Guggulsterone and its role in chronic diseases. Adv Exp Med Biol. 2016;929:329\u201361.","journal-title":"Adv Exp Med Biol"}],"container-title":["Chinese Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13020-025-01183-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13020-025-01183-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13020-025-01183-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T09:01:29Z","timestamp":1757408489000},"score":1,"resource":{"primary":{"URL":"https:\/\/cmjournal.biomedcentral.com\/articles\/10.1186\/s13020-025-01183-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,20]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1183"],"URL":"https:\/\/doi.org\/10.1186\/s13020-025-01183-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6377473\/v1","asserted-by":"object"}]},"ISSN":["1749-8546"],"issn-type":[{"value":"1749-8546","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,20]]},"assertion":[{"value":"5 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The animal study protocol was approved by the Experimental Animal Ethics Committee of Nanchang University (Approval Document: NCULAE-20240520002).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declared that they have no competing interests in this work.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"128"}}